GNH USA

Europe — EMA

Moxonidin Ratiopharm (Moxonidine)

GNH USA supplies Moxonidin Ratiopharm (Moxonidine), a imidazoline receptor agonist for essential hypertension. Request a quote for global worldwide supply.

Moxonidine

Request sourcing

1
Pack/s

What is Moxonidine?

Moxonidine, the active ingredient in Moxonidin Ratiopharm, is an imidazoline receptor agonist presented as a tablet for oral use. It treats essential hypertension by lowering elevated blood pressure in adult patients. GNH USA supplies Moxonidin Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Moxonidine used for?

Moxonidine is an antihypertensive that acts on the central imidazoline I1 receptors to control high blood pressure.

Essential hypertension: reduces systolic and diastolic pressure in patients with primary hypertension. Resistant hypertension: may be added when blood pressure remains uncontrolled despite other agents. Hypertension with high sympathetic activity: helps normalize sympathetic outflow and improve blood pressure control.

What are the side effects of Moxonidine?

Moxonidine may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Dry mouth - Dizziness - Fatigue - Headache

Serious or Rare Side Effects: - Severe hypotension - Bradycardia - Allergic reaction (rash, angioedema)

What precautions apply to Moxonidine?

Before initiating therapy with Moxonidine, several safety considerations should be observed. - Blood pressure monitoring: check regularly to avoid excessive hypotension. - Renal impairment: dose may need adjustment in patients with reduced kidney function. - Hepatic disease: use cautiously and monitor liver enzymes. - Elderly patients: start at lower dose and titrate slowly. - Store at below 25°C: keep in the original pack, protect from moisture.

What does Moxonidine interact with?

Moxonidine can interact with other medicines, requiring attention to avoid adverse effects.

Major Interactions (Avoid): - MAO inhibitors: may precipitate hypertensive crisis. - Clonidine: additive hypotensive effect can cause severe blood pressure drop. - Other central antihypertensives: risk of excessive hypotension.

Moderate Interactions (Monitor Closely): - Diuretics: may enhance antihypertensive response, requiring dose adjustment. - NSAIDs: can reduce the blood‑pressure‑lowering efficacy of Moxonidine.

Frequently asked questions

What is Moxonidin Ratiopharm used for?+
Moxonidin Ratiopharm contains the active substance moxonidine and is prescribed to lower elevated blood pressure in adults with essential hypertension. By reducing sympathetic nervous system activity, it helps achieve target blood‑pressure levels and lowers the risk of hypertension‑related complications.
How does moxonidine work?+
Moxonidine acts as a selective agonist at imidazoline I1 receptors in the brainstem. Stimulation of these receptors decreases sympathetic outflow, which reduces peripheral vascular resistance and cardiac output, ultimately leading to a fall in arterial blood pressure.
What is the usual dose of Moxonidin Ratiopharm?+
The appropriate dose is determined by the prescribing physician based on the individual’s blood‑pressure profile, response to therapy, and renal function. The prescriber will start with a low dose and may titrate upward to achieve optimal control while monitoring for side effects.
Is Moxonidin Ratiopharm safe during pregnancy or breastfeeding?+
Safety data in pregnancy and lactation are limited. The drug should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare professional.
How do I order Moxonidin Ratiopharm from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does moxonidine compare with other antihypertensive agents?+
Moxonidine differs from traditional alpha‑2 agonists such as clonidine by selectively targeting imidazoline I1 receptors, which often results in fewer sedative and dry‑mouth side effects. It is generally used when patients need a centrally acting agent with a more favorable tolerability profile.
What are the storage and handling requirements for Moxonidin Ratiopharm?+
Store the tablets at temperatures below 25 °C in their original container, protected from moisture and direct sunlight. Keep out of reach of children and do not use after the expiry date printed on the packaging.
How is Moxonidin Ratiopharm administered?+
Moxonidin Ratiopharm is taken orally, usually once daily. Swallow the tablet whole with a glass of water, preferably at the same time each day, unless the prescribing doctor advises a different schedule.
What are the most serious risks associated with Moxonidin Ratiopharm?+
The most serious adverse events include severe hypotension, marked bradycardia, and allergic reactions such as rash or angioedema. Patients should seek immediate medical attention if they experience faintness, rapid heartbeat, or signs of an allergic response.
Who should not use Moxonidin Ratiopharm?+
Moxonidin Ratiopharm is contraindicated in patients with known hypersensitivity to moxonidine or any excipients, those with severe hypotension, and individuals with certain cardiac conduction disorders. A healthcare professional should evaluate each patient’s medical history before initiating therapy.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Moxonidine
Route
Oral Use
Manufacturer
Ratiopharm Gmbh
Origin
EU

Related products

Cynt

Cynt

Moxonidine

Viatris Hrvatska D.O.O.
EU
Cynt

Cynt

Moxonidine

Viatris Healthcare Limited
EU
Cynt

Cynt

Moxonidine

Viatris Healthcare Limited
EU
Cynt

Cynt

Moxonidine

Biomin, A.S.
EU